<?xml version="1.0" encoding="UTF-8"?>
<p>To test the impact of camostat mesilate on COVID-19 Infection (CamoCO-19), an Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial is underway and its results are expected to be announced in December this year (
 <xref rid="B72" ref-type="bibr">72</xref>).
</p>
